DURVIEW
Live / Allowed — Fifth extension granted (statement of use) (as of 25 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Jun 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98048464
- Mark type
- Word mark
- Filed
- 19 Jun 2023
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Kimberly Jarman
Goods and services
- Class 005 — Pharmaceuticals: Injectable pharmaceutical preparations for use by ophthalmologists and other medical professionals for the treatment of eye diseases and conditions
Owner
- EYEPOINT US, INC., WATERTOWN, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
- EyePoint Pharmaceuticals US, Inc., Watertown, MA, US
Board proceedings on this mark
- Extension of Time to Oppose No. 98048464 — Novartis AG v. EyePoint Pharmaceuticals US, Inc., filed 28 Nov 2023 (Terminated)
Prosecution history
- 26 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2026 — SOU EXTENSION 5 GRANTED
- 14 Aug 2026 — SOU EXTENSION 5 FILED
- 25 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2026 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 03 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Feb 2026 — SOU EXTENSION 4 GRANTED
- 02 Feb 2026 — SOU EXTENSION 4 FILED
- 02 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Sept 2025 — SOU EXTENSION 3 GRANTED
- 03 Sept 2025 — SOU EXTENSION 3 FILED
- 03 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 20 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED